Greg Goldmacher

Associate VP, Clinical Research; Head of Clinical Imaging & Pathology

Greg has been at Merck since 2015, and is now Associate VP in Clinical Research, and Head of Clinical Imaging and Pathology. With his team of radiologists, pathologists, and research scientists, he oversees endpoint assessments in ~250 clinical trials in oncology, neuroscience, immunology, cardiovascular, infectious, and metabolic diseases. He also leads teams conducting research in artificial intelligence, tumor growth kinetics, novel response criteria, and other innovative approaches to clinical trial imaging. Prior to Merck, he was a senior medical director and head of oncology imaging at a global CRO, and before that in academia. He participates and has held leadership positions in QIBA, PINTAD, CDISC, RECIST, Project Data Sphere, and other industry and academic collaborations. His clinical training was in diagnostic radiology, along with a PhD and postdoctoral research in neuroscience, and business training in finance.

Talks About
#clinicalimaging #pathology

Preferred Locations
#NorthAmerica